United States next generation sequencing market is expected to grow at a significant rate during the forecast period. Strong economic growth of United States is enabling the concerned authorities to allocate huge funds for the research and development activities which is expected to fuel the demand for next generation sequencing in laboratories. Rise in disposable income of the consumers is increasing the healthcare expenditure of people. Next generation sequencing helps to devise effective treatments and formulate drugs with better outcomes. High-end investments by the major players for technological advancement and use of better equipment and tools for next generation sequencing is expected to influence the market growth. Next generation sequencing is highly sensitive to variants whose frequency is low. It has the ability to sequence a large number of genes simultaneously with fast turn around time. Higher amount of data is generated within a sample of DNA than the other present technologies. Next generation sequencing is widely used for infectious disease surveillance for producing high quality results. Increasing prevalence of terminal diseases requires the effective treatment strategies which can be obtained through next generation sequencing technology.

United States next generation sequencing market is segmented into product, technology, application, end user, regional distribution, and company. Based on end user, market is further divided into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The academic & clinical research centers segment is expected to account for major market share for the forecast period, 2022-2026. Applications of next generation sequencing for research projects is driving the demand in academic centers. Moreover, the scholarships offered to study next generation sequencing for Ph.D. is expected to foster the market growth.

The major players operating in the United States next generation sequencing market are Illumina, Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent Technologies, Inc., PerkinElmer Inc., Pacific Biosciences of California Inc, 10x Genomics Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of United States next generation sequencing market from 2016 to 2019.
  • To estimate and forecast the market size of United States next generation sequencing market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast United States next generation sequencing market based on product, technology, application, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States next generation sequencing.
  • To identify drivers and challenges for United States next generation sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States next generation sequencing market.
  • To identify and analyze the profile of leading players operating in United States next generation sequencing market.
  • To identify key sustainable strategies adopted by market players in United States next generation sequencing market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States next generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Next generation sequencing provider companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to next generation sequencing market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States next generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Next Generation Sequencing Market, By Product:

    • Consumables
    • Platforms
    • Services
  • United States Next Generation Sequencing Market, By Technology:
    • Sequencing by Synthesis
    • Ion Semiconductor Sequencing
    • Sequencing by Ligation
    • Single Molecule Real Time Sequencing
    • Others
  • United States Next Generation Sequencing Market, By Application:
    • Biomarkers & Cancer
    • Diagnostics
    • Reproductive Health
    • Personalized Medicine
    • Agriculture & Animal Research
    • Others
  • United States Next Generation Sequencing Market, By End User:
    • Academic & Clinical Research Centers
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinics
    • Others
  • United States Next Generation Sequencing Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States next generation sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States next generation sequencing market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Next Generation Sequencing Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Next Generation Sequencing Market Overview

7.    United States Next Generation Sequencing Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Consumables, Platforms, Services)

7.2.2.     By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others)

7.2.3.     By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others)

7.2.4.     By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)

7.2.5.     By Region

7.2.6.     By Company (2020)

7.3.  Product Market Map

8.    United States Next Generation Sequencing By Synthesis Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By End User

9.    United States Ion Semiconductor Sequencing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By End User

10.  United States Sequencing By Ligation Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Application

10.2.3.  By End User

11.  United States Single Molecule Real Time Sequencing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Application

11.2.3.  By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Policy & Regulatory Landscape

15.  United States Economic Profile

16.  Competitive Landscape

16.1.              Competition Outlook

16.2.              Company Profiles

16.2.1.  Illumina, Inc.

16.2.2.  Thermo Fischer Scientific, Inc.

16.2.3.  Roche Diagnostics Corporation

16.2.4.  Agilent Technologies, Inc.

16.2.5.  PerkinElmer Inc.

16.2.6.  Pacific Biosciences of California Inc

16.2.7.  10x Genomics Inc.

16.2.8.  Amgen Inc.

16.2.9.  Bio-Rad Laboratories, Inc.

16.2.10.                QIAGEN Inc.

17.  Strategic Recommendations

18.  About us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]